| BIOVENTUS INC. A DL -001 |
| USA |
| US09075A1088 / A2APNA |
| 4B8 (Frankfurt) / BVS (NASDAQ) |
| FRA:4B8, ETR:4B8, 4B8:GR, NASDAQ:BVS |
| - |
| - |
|
Bioventus Inc. Class A Common Stock represents ownership in Bioventus Inc., a medical technology company headquartered in Durham, North Carolina. Bioventus focuses on developing and commercializing orthobiologic and musculoskeletal treatments that en..
>Volltext.. |
| 975.8 Mio. EUR |
| 1233.17 Mio. EUR |
| 499.78 Mio. EUR |
| 93.38 Mio. EUR |
| 24.7 Mio. EUR |
| 0.37 EUR |
| 250.12 Mio. EUR |
| 31.09 Mio. EUR |
| 88.67 Mio. EUR |
| 0.24 |
| -4.94% |
| - |
| - |
| - |
| - |
| - |
| 05.08.26 |
|